AMEH
Apollo Medical
–
Index: NASDAQ; Sector: Healthcare; Industry: Healthcare Facilities;
Marketcap: 929.00M; Volume: 50.23K; AvgVol 3m: 103.83K; Beta: 0.77;
Cost estimate:
P/E: 29.50; EPS: 0.59; EPS growth quarter/prev quarter: 102.30%;
EPS growth this year: 35.70%; EPS growth past 5 years: 25.00%;
EPS ttm: 0.59;
P/S: 1.42; P/B: 3.11; P/Cashflow: 3.49; P/FCF: 19.96;
Sales: 665.08M; Sales growth quarter/prev quarter: 27.10%; Sales growth past 5 years: 76.20%;
Profitability:
Gross Margin: 15.30%; Profit Margin: 3.20%; Operating Margin: 5.80%;
ROA – return on assets: 2.80%; ROE – return on equity: 11.00%; LT Debt/Equity: 1.11; Total Debt/Equity: 1.16;
Dividend: –; Dividend Yield (%): –;
Insider Ownership: 5.30%; Insider Transactions:-0.03%;
Institutional Ownership: 8.00%; Institutional Transactions: 19.87%;
Data update: 07/10/2020.